Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-21 4:17 pm Sale | 13D | ICOSAVAX INC ICVX | RA CAPITAL MANAGEMENT L.P. | 0 0% | -5,985,843 (Position Closed) | View |
| 2024-02-14 9:08 pm Sale | 13G | EYEPOINT PHARMACEUTICALS, INC. EYPT | RA CAPITAL MANAGEMENT L.P. | 3,095,136 6.1% | -313,570 (-9.20%) | View |
| 2024-02-14 6:41 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | RA CAPITAL MANAGEMENT L.P. | 3,472,106 9.99% | 1,417 (+0.04%) | View |
| 2024-02-14 6:35 pm Unchanged | 13G | ORCHARD THERAPEUTICS PLC ADS N ORTX | RA CAPITAL MANAGEMENT L.P. | 0 0% | 0 (Unchanged) | View |
| 2024-02-14 5:17 pm Purchase | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA CAPITAL MANAGEMENT L.P. | 6,179,035 15.2% | 19,981 (+0.32%) | View |
| 2024-02-14 5:04 pm Unchanged | 13G | TOURMALINE BIO INC TRML | RA CAPITAL MANAGEMENT L.P. | 0 0% | 0 (Unchanged) | View |
| 2024-02-14 5:03 pm Sale | 13G | NEKTAR THERAPEUTICS NKTR | RA CAPITAL MANAGEMENT L.P. | 0 0% | -18,700,000 (Position Closed) | View |
| 2024-02-14 5:01 pm Purchase | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | RA CAPITAL MANAGEMENT L.P. | 4,163,211 9.7% | 1,373,490 (+49.23%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | AN2 THERAPEUTICS INC ANTX | RA CAPITAL MANAGEMENT L.P. | 5,551,295 18.7% | 1,777,778 (+47.11%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | CHIMERIX INC CMRX | RA CAPITAL MANAGEMENT L.P. | 8,800,000 9.9% | 2,298,376 (+35.35%) | View |
| 2024-02-14 5:01 pm Sale | 13G | CUREVAC N V CUREVAC N V IN CON CVAC | RA CAPITAL MANAGEMENT L.P. | 2,744,270 1.2% | -9,501,685 (-77.59%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | IMMUNOGEN INC IMGN | RA CAPITAL MANAGEMENT L.P. | 26,916,027 9.99% | 4,840,869 (+21.93%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | ALPINE IMMUNE SCIENCES INC ALPN | RA CAPITAL MANAGEMENT L.P. | 5,903,234 9.99% | 1,505,866 (+34.24%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | RA CAPITAL MANAGEMENT L.P. | 10,107,400 17.5% | 140,228 (+1.41%) | View |
| 2024-02-14 5:01 pm Sale | 13G | AVIDITY BIOSCIENCES INC RNA | RA CAPITAL MANAGEMENT L.P. | 2,454,533 3.3% | -3,000,000 (-55.00%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | RA CAPITAL MANAGEMENT L.P. | 7,809,852 9% | 769,230 (+10.93%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | FULCRUM THERAPEUTICS INC FULC | RA CAPITAL MANAGEMENT L.P. | 11,609,704 18.8% | 1,923,076 (+19.85%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | GERON CORP GERN | RA CAPITAL MANAGEMENT L.P. | 55,145,502 9.99% | 6,722,291 (+13.88%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | GH RESH PLC SHS GHRS | RA CAPITAL MANAGEMENT L.P. | 5,587,333 10.7% | 26,215 (+0.47%) | View |
| 2024-02-14 5:01 pm Sale | 13G | GRACELL BIOTECHNOLOGIES INC SP GRCL | RA CAPITAL MANAGEMENT L.P. | 48,600,221 9.99% | -79 (-0.00%) | View |